Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer Survivors Program: Effectiveness of Monitoring Adverse Events After Completion of Curative Treatment for Breast and Prostate Cancer

NCT07253987 is registered in ClinicalTrials.gov with Masaryk Memorial Cancer Institute as lead sponsor.

NCT NCT07253987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07253987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer Survivors Program: Effectiveness of Monitoring Adverse Events After Completion of Curative Treatment for Breast and Prostate Cancer
Lead sponsor
Masaryk Memorial Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
May 5, 2025
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer patients, prostate cancer patients